arrow_right
Pivotal Study Design
PIVOTAL CLINICAL VALIDATION STUDY DESIGN
Percepta GSC was validated in a prospective, multicenter, blinded study on a combined cohort of 412 patients from AEGIS I1, AEGIS II1 and PERCEPTA Registry2. All patients met inclusion criteria and had an inconclusive bronchoscopy:
ADDITIONAL CLINICAL STUDIES
CONTACT A REP TO ORDER VERACYTE TESTING
Veracyte representatives are happy to assist you and to discuss how to integrate our tests into your practice.
First Name*
Last Name*
Email*
Institution/Practice*
Zip Code*
Which Test Interests You?*
More About You*
Message
CONTACT REP
R E F E R E N C E S 
1. Silvestri GA et al. New England Journal of Medicine. 2015.
2. Lee HJ et al. Oral presentation at CHEST 2018.
© 2021 Veracyte, Inc. All rights reserved.